As of 2026-05-13, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (70.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.00 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -319.8%.
The range of the Relative Valuation is (67.64) - (68.99) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 23.3x | 21.5x |
| Forward P/E multiples | 20.1x - 20.5x | 20.3x |
| Fair Price | (67.64) - (68.99) | (70.33) |
| Upside | -311.4% - -315.6% | -319.8% |
| Date | P/E |
| 2026-05-11 | -9.59 |
| 2026-05-08 | -10.09 |
| 2026-05-07 | -9.90 |
| 2026-05-06 | -10.22 |
| 2026-05-05 | -10.06 |
| 2026-05-04 | -9.74 |
| 2026-05-01 | -9.60 |
| 2026-04-30 | -9.77 |
| 2026-04-29 | -9.55 |
| 2026-04-28 | -9.87 |
| 2026-04-27 | -10.00 |
| 2026-04-24 | -9.89 |
| 2026-04-23 | -9.97 |
| 2026-04-22 | -10.17 |
| 2026-04-21 | -10.18 |
| 2026-04-20 | -10.22 |
| 2026-04-17 | -10.27 |
| 2026-04-16 | -10.06 |
| 2026-04-15 | -10.06 |
| 2026-04-14 | -9.90 |
| 2026-04-13 | -9.68 |
| 2026-04-10 | -9.58 |
| 2026-04-09 | -9.99 |
| 2026-04-08 | -9.63 |
| 2026-04-07 | -9.32 |
| 2026-04-06 | -9.32 |
| 2026-04-02 | -9.23 |
| 2026-04-01 | -9.29 |
| 2026-03-31 | -9.43 |
| 2026-03-30 | -8.76 |
| 2026-03-27 | -9.00 |
| 2026-03-26 | -9.43 |
| 2026-03-25 | -9.41 |
| 2026-03-24 | -9.27 |
| 2026-03-23 | -9.45 |
| 2026-03-20 | -9.18 |
| 2026-03-19 | -8.92 |
| 2026-03-18 | -8.48 |
| 2026-03-17 | -8.81 |
| 2026-03-16 | -8.97 |
| 2026-03-13 | -8.77 |
| 2026-03-12 | -8.88 |
| 2026-03-11 | -9.28 |
| 2026-03-10 | -9.26 |
| 2026-03-09 | -9.13 |
| 2026-03-06 | -8.75 |
| 2026-03-05 | -8.72 |
| 2026-03-04 | -8.78 |
| 2026-03-03 | -8.60 |
| 2026-03-02 | -8.91 |